Table 2-8Deterministic results

Deterministic results
Patients admitted for treating AAWPatients admitted for treating a co- morbid condition
AnalysisDaeppenSaitzLange- AsschenfeldWeaver
Base case analysis
Dominant (£398)*Dominant (£551)*Dominant (£723)*Dominant (£27)*
Sensitivity analysis
Remove hospitalisation costDominant (£6)*Dominant (£13)*Dominant (£2)*n/a
Using other drug 1Dominant (£395)*Dominant (£557)*n/aDominant (£54)*
Using other drug 2n/an/an/aDominant (£16)*
Inpatient cost £254 per dayDominant (£461)*Dominant (£637)*Dominant (£838)*n/a
Inpatient cost £271 per dayDominant (£491)*Dominant (£679)*Dominant (£894)*n/a
No. of assessment (favour S-T)Dominant (£408)*Dominant (£559)*Dominant (£752)*Dominant (£43)*
No. of assessment (favour F-D)Dominant (£379)*Dominant (£544)*Dominant (£698)*Dominant (£2)*
Nurse cost - Band 6Dominant (£399)*Dominant (£554)*Dominant (£723)*Dominant (£29)*
Time per nurse assessmentDominant (£376)*Dominant (£533)*Dominant (£671)*ICER = £7,489/QALY**
Nurse cost – adding non-contact timeDominant (£400)*Dominant (£563)*Dominant (£723)*Dominant (£33)*
Probabilistic results
Base-case analysisDominant (£396)*Dominant (£563)*Dominant (£735)*Dominant (£29)*
*

The symptom-triggered regimen is more efficient and less costly compared to the fixed-dosing regimen (total cost saved per patient using the symptom-triggered regimen is presented).

**

The symptom-triggered regimen is more effective and more costly compared to the fixed-dosing regimen; the Incremental Cost-Effectiveness Ratio (ICER) is presented (which is below the NICE threshold of £20k/QALY gained).

From: 2, Acute Alcohol Withdrawal

Cover of Alcohol Use Disorders
Alcohol Use Disorders: Diagnosis and Clinical Management of Alcohol-Related Physical Complications [Internet].
NICE Clinical Guidelines, No. 100.
National Clinical Guideline Centre (UK).
Copyright © 2010, National Clinical Guidelines Centre.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.